Liang Xu

12PUBLICATIONS
55CO-AUTHORS
Molecular targetsSolid tumoursEpidemiological modellingGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 19, 2026
Harnessing MDM2-Mediated Targeted Degradation of Transcriptional and Epigenetic Machinery to Disrupt Oncogenic Addictions in Pediatric Sarcoma.

|Apr 16, 2026
XPO1 inhibitor KPT-330 disrupts the core transcriptional regulatory circuitry of dedifferentiated liposarcoma by modulating the translation process.

|Jan 06, 2026
A fibroblast-like endothelial cell state promotes atherosclerosis via C/EBPβ-activated TGF-β signaling.

Linge Fan, Yingyi Zhu, Yi Li

|Jan 13, 2023
Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy.

Xue-Bin Ran, Ling-Wen Ding, Qiao-Yang Sun

|Mar 17, 2022
The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma.

Cunjie Chang, Muthukumar Rajasekaran, Yiting Qiao

|May 01, 2021
Topography of transcriptionally active chromatin in glioblastoma.

Liang Xu, Ye Chen, Yulun Huang

Pageof 2

Frequent Collaborators

4 joint publications

Ye Chen

3 joint publications

H Phillip Koeffler

3 joint publications

Tuan Zea Tan

2 joint publications

Vikas Madan